Ariceum International AG

Swiss Biotech Association

Member

Ariceum International AG is the Swiss affiliate of Ariceum Therapeutics GmbH, a private, clinical stage radiopharmaceutical company focused on the diagnosis and precision treatment of hard-to-treat cancers. Ariceum’s lead targeted systemic radiopharmaceutical product, 177Lu-satoreotide tetraxetan.

Products, services, technology

SSO110, 177Lu-satoreotide tetraxetan (Satoreotide), is an antagonist of the somatostatin type 2 receptor (SSTR2) in clinical development stage in neuroendocrine tumours.

Location

Aeschengraben 29, 4051 Basel, Switzerland

Get Directions

Facts & figures

Type of organization

Private company
Year of foundation

2023
Number of employees in Switzerland

1-9

Key business

Core competencies

You may also be interested in

Solvias AG

Solvias is a contract research, development & manufacturing
We offer early phase development of small molecules API by process R&D and GMP-manufacturing integrated with high through-put screening, solid state and a wide ligand portfolios for catalytic transformations and analytical services.
Kaiseraugst

Member

Porton Pharmaceutical Chemicals GmbH

Porton Pharma is a a leading CDMO with operations and commercial offices across the US, EU and China. Porton Pharma provides global pharmaceutical companies with innovative, reliable and end-to-end process R&D and manufacturing services across small molecules, dosage forms and biologics.
6039 Root

Member

Bavarian Nordic Berna GmbH

Bavarian Nordic is a fully integrated vaccine company focused on the development, manufacturing and commercialization of life-saving vaccines. Our manufacturing site for oral vaccines is located in Thörishaus, 15 km southwest of Bern.
3174 Thörishaus

Member